Stanislas-Léonard Malmezat

Stanislas MALMEZAT is Chief Financial Officer of Domain Therapeutics. He joined the company in 2018 to structure and develop the financial department as well as to assist the CEO in fundraising and strategic development. Prior to joining Domain Therapeutics, he developed extensive operational background during more than 6 years as CFO at Rarecells Diagnostics and later at CleveXel Pharma. Before that, he acquired a solid experience in corporate finance working in a French Venture Capital fund specializing in Biotechnology then as a consultant in the Corporate Restructuring & Transaction Services department of Ernst & Young, and later, at Duff & Phelps Paris in Merger and Acquisition operations. Stanislas started his career in the pharmaceutical industry as a Product Manager at Johnson & Johnson. He has a Ph.D. in pharmacy and is a graduate of the ESSEC Business School, Paris, France.